IL-1beta converting enzyme inhibitors (Kyowa Hakko)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameIL-1beta converting enzyme inhibitors (Kyowa Hakko)
Drug Alias NameIL-1 synthesis inhibitors (Kyowa Hakko)EI-1941-1EI-1941-2EI-2346EI-2128-1
ClassificationSmall molecules
Mechanisms of ActionCaspase-1 inhibitors
TargetsCaspase-1
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKyowa Hakko Kogyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKyowa Hakko Kogyo Co Ltd
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A